Drug Engineered at UT Austin to Treat Anthrax Gains FDA Approval
The anthrax antitoxin obiltoxaximab received approval March 21 from the U.S. Food and Drug Administration (FDA).
Jekyll and Hyde Bacteria
What do you do when the bacteria you study that's deadly in the real world acts all mild and gentle in the lab?
Trapping a Bacterium in a Laser Beam Aids Study of Biofilms
Biofilms are responsible for most chronic infections and are notoriously resilient and hard to treat.
